We form strategic partnerships with pharmaceutical companies to develop and commercialize leading original medicines, ensuring patients get the treatment they need.
Bringing the world’s most innovative and proven medicines to Latin America
Oct 03, 2022
moksha8 officially rebrands as M8 Pharmaceuticals
May 05, 2022
M8 Pharmaceuticals Announces approval of Mokbio® PS128™ in Mexico
Oct 05, 2021
M8 Pharmaceuticals Announces License of Exclusive Mexican Rights for Arlevert® from HENNIG ARZNEIMITTEL
Sep 14, 2021
M8 Pharmaceuticals Announces License of Exclusive rights for Diacomit® (Stiripentol) from Biocodex SAS
Portfolio
Fortified by a commitment to integrity and care for patients, M8 focuses on the following therapeutic areas.
Partnerships
At M8, we have a strong track record as a true partner in long-standing alliances with global pharmaceutical companies, supporting them in bringing their innovation from the regulatory stage through full commercialization.
